BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34860558)

  • 1. Novel Program Offering Remote, Asynchronous Subspecialist Input in Thoracic Oncology: Early Experience and Insights Gained During the COVID-19 Pandemic.
    West HJ; Tan YA; Barzi A; Wong D; Parsley R; Sachs T
    JCO Oncol Pract; 2022 Apr; 18(4):e537-e550. PubMed ID: 34860558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave.
    Bertaglia V; Reale ML; Bironzo P; Palesandro E; Mariniello A; Leone G; Tabbò F; Bungaro M; Audisio M; Rapetti S; Di Stefano RF; Carnio S; Artusio E; Capelletto E; Sperone P; Passiglia F; Novello S
    Crit Rev Oncol Hematol; 2021 Jan; 157():103189. PubMed ID: 33341505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended Delay to Treatment for Stage III-IV Non-Small-Cell Lung Cancer and Survival: Balancing Risks During the COVID-19 Pandemic.
    Mayne NR; Bajaj SS; Powell J; Elser HC; Civiello BS; Fintelmann FJ; Li X; Yang CJ
    Clin Lung Cancer; 2022 Sep; 23(6):e362-e376. PubMed ID: 35660355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of Lung Cancer Patient Characteristics and Treatment Strategies in the Pandemic Covid-19 Year.
    Crvenkova S; Jakimovki D; Ristovski V
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2023 Mar; 44(1):105-115. PubMed ID: 36987767
    [No Abstract]   [Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and Survival Analysis Before and After Implementation of Dana-Farber Clinical Pathways for Patients With Stage IV Non-Small-Cell Lung Cancer.
    Jackman DM; Zhang Y; Dalby C; Nguyen T; Nagle J; Lydon CA; Rabin MS; McNiff KK; Fraile B; Jacobson JO
    J Oncol Pract; 2017 Apr; 13(4):e346-e352. PubMed ID: 28260402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic and Clinical Outcomes of Brazilian Patients With Stage III or IV Non-Small-Cell Lung Cancer: Real-World Evidence Study on the Basis of Deterministic Linkage Approach.
    Ferreira CG; Abadi MD; de Mendonça Batista P; Serra FB; Peixoto RB; Okumura LM; Cerqueira ER
    JCO Glob Oncol; 2021 Sep; 7():1454-1461. PubMed ID: 34609902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Br J Cancer; 1995 Nov; 72(5):1270-7. PubMed ID: 7577481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of COVID-19 Pandemic on Non-Small Cell Lung Cancer Care.
    Zhai Y; Chopra P; Kang D; Robert NJ; Zhang W
    Curr Oncol; 2023 Jan; 30(1):769-785. PubMed ID: 36661708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
    Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
    Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea.
    Park JY; Lee YJ; Kim T; Lee CY; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Jang SH
    BMC Cancer; 2020 Oct; 20(1):1040. PubMed ID: 33121456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auditing a new lung cancer service.
    Cullen JP; Glynn C; Murtagh E; Hogan B; Jeffers M; Lane SJ
    Ir Med J; 2004 Oct; 97(9):281-3. PubMed ID: 15568588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the quality of lung cancer care in Ontario: the lung cancer disease pathway initiative.
    Evans WK; Ung YC; Assouad N; Chyjek A; Sawka C
    J Thorac Oncol; 2013 Jul; 8(7):876-82. PubMed ID: 23575416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus statement: summary of the Quebec Lung Cancer Network recommendations for prioritizing patients with thoracic cancers in the context of the COVID-19 pandemic.
    Blais N; Bouchard M; Chinas M; Lizotte H; Morneau M; Spicer J; Martel S
    Curr Oncol; 2020 Jun; 27(3):e313-e317. PubMed ID: 32669938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of lung cancer in Turkey.
    Cakir Edis E; Karlikaya C
    Tuberk Toraks; 2007; 55(1):51-8. PubMed ID: 17401794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study.
    Stone E; Rankin N; Kerr S; Fong K; Currow DC; Phillips J; Connon T; Zhang L; Shaw T
    Lung Cancer; 2018 Oct; 124():199-204. PubMed ID: 30268461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report.
    Mynard N; Saxena A; Mavracick A; Port J; Lee B; Harrison S; Chow O; Villena-Vargas J; Scheff R; Giaccone G; Altorki N
    Clin Lung Cancer; 2022 May; 23(3):e238-e242. PubMed ID: 34580031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.